178 companies

High Tide

Market Cap: CA$287.3m

Engages in the cannabis retail business in Canada, the United States, and internationally.

HITI

CA$3.25

7D

2.4%

1Y

-3.6%

Trulieve Cannabis

Market Cap: US$1.8b

Operates as a cannabis retailer in the United States.

TRLV

US$9.11

7D

7.9%

1Y

1.2%

Oxford Biomedica

Market Cap: UK£596.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

OXB

UK£4.93

7D

-14.2%

1Y

10.9%

Hypera

Market Cap: R$15.2b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$21.57

7D

1.1%

1Y

-6.2%

CorMedix

Market Cap: US$572.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$7.10

7D

-4.2%

1Y

-41.2%

Innovent Biologics

Market Cap: HK$166.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

1801

HK$95.15

7D

4.6%

1Y

-0.9%

UCB

Market Cap: €42.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

UCB

€221.80

7D

-3.2%

1Y

16.6%

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$9.97

7D

7.1%

1Y

-18.3%

Elanco Animal Health

Market Cap: US$11.4b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$22.13

7D

-15.6%

1Y

24.3%

Kuros Biosciences

Market Cap: CHF 912.4m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

KURN

CHF 23.00

7D

-1.7%

1Y

-13.5%

Yunnan Baiyao GroupLtd

Market Cap: CN¥90.2b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥50.46

7D

-0.5%

1Y

-9.7%

Hugel

Market Cap: ₩2.9t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

A145020

₩262,500.00

7D

-5.9%

1Y

-17.2%

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

VIRP

€333.50

7D

-1.5%

1Y

1.2%

Bavarian Nordic

Market Cap: DKK 13.8b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 180.70

7D

0.8%

1Y

-24.4%

Diaceutics

Market Cap: UK£120.1m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.42

7D

-2.4%

1Y

2.9%

Prestige Consumer Healthcare

Market Cap: US$2.5b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

PBH

US$52.27

7D

-1.3%

1Y

-21.3%

Dong-E-E-Jiao

Market Cap: CN¥33.8b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

000423

CN¥52.68

7D

-2.2%

1Y

5.0%

Cresco Labs

Market Cap: CA$493.2m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

New

CL

CA$1.06

7D

17.8%

1Y

-29.3%

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

DB

CA$0.12

7D

9.5%

1Y

-8.0%

Journey Medical

Market Cap: US$174.0m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

DERM

US$6.43

7D

0.5%

1Y

-11.3%

Fennec Pharmaceuticals

Market Cap: US$447.7m

Operates as a commercial stage biopharmaceutical company in the United States.

FENC

US$11.83

7D

12.5%

1Y

29.9%

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.22

7D

0.8%

1Y

-6.2%

Dong-A ST

Market Cap: ₩375.9b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

A170900

₩38,150.00

7D

0.8%

1Y

-13.0%

Amoy Diagnostics

Market Cap: CN¥7.2b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

300685

CN¥19.75

7D

13.1%

1Y

-16.0%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€57.80

7D

-1.4%

1Y

3.3%

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

DMP

€40.05

7D

-2.7%

1Y

23.4%

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

PRGO

US$12.69

7D

-4.4%

1Y

-46.4%

Daewoong Pharmaceutical

Market Cap: ₩1.4t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

A069620

₩124,000.00

7D

-3.1%

1Y

-7.5%

United Laboratories International Holdings

Market Cap: HK$17.8b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

3933

HK$8.95

7D

-0.3%

1Y

-42.6%

China Resources Pharmaceutical Group

Market Cap: HK$30.8b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

3320

HK$4.89

7D

2.4%

1Y

-7.0%

Protara Therapeutics

Market Cap: US$231.1m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

TARA

US$3.89

7D

-2.8%

1Y

19.3%

Curaleaf Holdings

Market Cap: CA$3.7b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

CURA

CA$13.80

7D

17.8%

1Y

8.7%

Verastem

Market Cap: US$638.5m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

VSTM

US$6.95

7D

18.4%

1Y

-13.3%

Cellectis

Market Cap: €193.4m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

ALCLS

€2.66

7D

7.1%

1Y

7.5%

Vanda Pharmaceuticals

Market Cap: US$298.1m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$5.19

7D

2.0%

1Y

19.0%

H. Lundbeck

Market Cap: DKK 40.1b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 41.68

7D

0.4%

1Y

17.1%

Page 1 of 5